Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (471-480 of 532) with videos related to

Pageof 54
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 5, 2006
Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout miceMichael A Ansonoff, Jiwen Zhang, Traci Czyzyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonistE J Bilsky, S N Calderon, T Wang, et al.
Journal of Medicinal Chemistry|August 1, 1989
Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligandsB R de Costa, W D Bowen, S B Hellewell, et al.
Nature|December 14, 2018
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndromeVerena Staedtke, Ren-Yuan Bai, Kibem Kim, et al.
Journal of Medicinal Chemistry|June 1, 1989
Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitroC H Kim, R B Rothman, A E Jacobson, et al.
Journal of Medicinal Chemistry|November 22, 1996
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)D Matecka, R B Rothman, L Radesca, et al.
Journal of Medicinal Chemistry|November 1, 1990
Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probesB R de Costa, K C Rice, W D Bowen, et al.
American Journal of Respiratory Cell and Molecular Biology|June 21, 2003
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressorHan Kim, Guo-Liang Xu, Alain C Borczuk, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Journal of Medicinal Chemistry|June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonistsJ B Thomas, S W Mascarella, R B Rothman, et al.
Pageof 54

Showing results (471-480 of 532) with videos related to

Sort By:
Pageof 54
The Journal of Pharmacology and Experimental Therapeutics|May 5, 2006
Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout miceMichael A Ansonoff, Jiwen Zhang, Traci Czyzyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonistE J Bilsky, S N Calderon, T Wang, et al.
Journal of Medicinal Chemistry|August 1, 1989
Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligandsB R de Costa, W D Bowen, S B Hellewell, et al.
Nature|December 14, 2018
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndromeVerena Staedtke, Ren-Yuan Bai, Kibem Kim, et al.
Journal of Medicinal Chemistry|June 1, 1989
Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitroC H Kim, R B Rothman, A E Jacobson, et al.
Journal of Medicinal Chemistry|November 22, 1996
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)D Matecka, R B Rothman, L Radesca, et al.
Journal of Medicinal Chemistry|November 1, 1990
Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probesB R de Costa, K C Rice, W D Bowen, et al.
American Journal of Respiratory Cell and Molecular Biology|June 21, 2003
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressorHan Kim, Guo-Liang Xu, Alain C Borczuk, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Journal of Medicinal Chemistry|June 20, 1998
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonistsJ B Thomas, S W Mascarella, R B Rothman, et al.
Pageof 54